Appeal No. 2001-1335 Application No. 08/843,582 its 7-epimer from ancistrocladus abbreviatus,” Phytochemistry, Vol. 30, No. 4, pp. 1307-1310 (1991). Bringmann et al. (Bringmann I), “Ancistrobrevine B, the first naphthylisoquinoline alkaloid with a 5,8'coupling site, and related compounds from ancistrocladus abbreviatus,” Phytochemistry, Vol. 31, No. 11, pp. 4011-4014 (1992). Bringmann et al. (Bringmann IV), “Dioncophylline C from the roots of triphyophyllum peltatum, the first 5,1'-coupled dioncophyllaceae alkaloid,” Phytochemistry, Vol. 31, No. 11, pp. 4019-4024 (1992). Bringmann et al. (Bringmann VI), “A new atropisomeric dioncophyllline A derivative from triphyophyllum peltatum,” Planta Med., 59 Supplemental Issue (1993). Claim 28 stands rejected under 35 U.S.C. § 102(e) as being anticipated by Bringmann III. Claims 28-33 stand rejected under 35 U.S.C. § 103(a) as being unpatentable over Bringmann I or Bringmann II or Bringmann IV in view of Sloan and Bundgaard, and claims 34-45 stand correspondingly rejected as being unpatentable over these references and further in view of Bringmann V and Bringmann VI and Ruangrungsi. We refer to the brief and to the answer for a complete exposition of the opposing viewpoints expressed by the appellants and by the examiner concerning the above noted rejections. OPINION For the reasons which follow, we cannot sustain any of the rejections advanced by the examiner on this appeal. 3Page: Previous 1 2 3 4 5 6 7 8 9 10 11 NextLast modified: November 3, 2007